Charles Schwab Investment Management Inc. raised its holdings in shares of Schrödinger, Inc. (NASDAQ:SDGR – Free Report) by 2 ...

In this article, we are going to take a look at where Schrödinger, Inc. (NASDAQ:SDGR) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up ...

NEW YORK, February 20, 2025--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on February 17, 2025, the company granted restricted stock units (RSUs) with respect to 5,445 shares of the ...

Schrodinger Inc (NASDAQ:SDGR) exceeded software revenue expectations in 2024, with a total software revenue of $180 million, representing a growth of over 13%. The company established a new drug ...

Thank you for standing by. Welcome to Schrödinger's conference call to review Fourth Quarter and Full Year 2024 Financial Results. My name is Kevin, and I'll your operator for today's call. All ...

In trading on Tuesday, shares of Schrodinger Inc (Symbol: SDGR) crossed below their 200 day moving average of $20.81, changing hands as low as $20.21 per share. Schrodinger Inc shares are ...

Short interest in Schrodinger Inc (NASDAQ:SDGR) decreased during the last reporting period, falling from 9.94M to 9.25M. This put 23.19% of the company's publicly available shares short.

Net Cash Used in Operating Activities (Full-Year 2024): $157 million, compared to $137 million in 2023. Schrodinger Inc (NASDAQ:SDGR) exceeded software revenue expectations in 2024, with a total ...